Aims-To examine the distribution of PAI-i antigen in normal and cirrhotic liver and liver with metastases. Methods-Sections of normal and cirrhotic liver and liver with metastases were stained using the alkaline phosphatase antialkaline phosphatase ( Tissue plasminogen activator (t-PA) is the principal circulating activator of the fibrinolytic system. t-PA is absorbed along with plasminogen on to fibrin; thus juxtaposed, they generate plasmin, which lyses the fibrin deposit.
Tissue plasminogen activator (t-PA) is the principal circulating activator of the fibrinolytic system. t-PA is absorbed along with plasminogen on to fibrin; thus juxtaposed, they generate plasmin, which lyses the fibrin deposit.
Control of t-PA in the circulation is secured by two main mechanisms. Firstly t-PA is inhibited directly and, secondly, it is cleared from the circulation by the liver. In both processes plasminogen activator inhibitor (PAI-1) has an important role. It is the primary plasma protein inhibiting t-PA, other inhibitors such as C I-esterase inhibitor and a2 macroglobulin having a secondary role.' PAI-I also participates in clearance of t-PA by the liver; t-PA in complex with PAI-I clears more rapidly than free t-PA.2 A specific hepatic receptor for t-PA-PAI-I complex has been shown,' in addition to the mannose and galactose receptors that clear free t-PA.48
The liver contains PAI-19 and hepatocytes in culture release PAI-1. 10 In situ hybridisation using a PAI-1 probe failed to show PAI-1 mRNA in rat hepatocytes,"1 but PAI-1 mRNA has been shown in rat liver regenerating after injury to the liver.'2 13 The role of hepatic PAI-1 is presently undefined and its relation to plasma PAI-1 and direct inhibition of t-PA or to clearance of t-PA from plasma remains to be established. The location and distribution of PAI-I in normal liver is not known.
In hepatic cirrhosis "overall plasma fibrinolytic activity" is increased suggesting that t-PA concentrations are raised. 1416 t-PA and PAI-I antigen concentrations are in fact both strikingly raised in cirrhosis,'7 18 but these observations do not distinguish between free (active) or complexed (inactive) forms of these molecules. The enhanced fibrinolytic activity in cirrhosis has been shown to be due in part to reduced clearance of t-PA." Patients with disseminated carcinoma frequently have reduced plasma fibrinolytic activity and raised plasma concentrations of PAI-1.920 Such patients additionally show a reduced fibrinolytic response to stimuli such as nicotinic acid. '5 Methods Liver sections fixed in 10% neutral buffered formalin and 4 iim in thickness were obtained from the pathology department of the University of Aberdeen. In addition, portions of fresh liver biopsy specimens were obtained before fixation. Normal liver and liver affected by alcoholic cirrhosis (n = 10), primary biliary cirrhosis (n = 5), metastatic carcinoma (n = 10), and primary hepatocellular carcinoma (n = 5) were studied. The diagnoses were based on the biopsy result and the results of liver function tests at the time of biopsy.
Tissue sections were stained using the APAAP technique, which was essentially the method described by Cordell et al. 21 The primary antibody, mouse antibody to human PAI-1 monoclonal antibody,22 was applied to the sections for 1 hour in a moist chamber at room temperature. Optimal dilutions of antibody were found by experiment to be 1 in 200 and 1 in 400. Control sections were stained with a monoclonal antibody of the same subclass (IgG,), raised against human neurofilament protein. This antibody was used at a dilution of 1 in 10.
The slides were then washed in 50 mM TRIS-buffered saline (TBS) (pH 7 6), and : : r P . . . ; 4 > t - IB) .
In the 10 cases of hepatic cirrhosis stained using the APAAP technique most showed a dramatic reduction in PAI-1 content of liver parenchyma compared with the normal liver sections (fig 2) . Variable PAI-1 staining was found in the fibrous tissue in cirrhotic liver, as in the connective tissue of normal liver.
Sections of liver affected by primary biliary cirrhosis showed a similar lack of PAI-1 staining, with a variable amount of staining of fibrous tissue (not shown).
Livers with metastases showed a variable amount of PAI-I staining, some with slightly more than the normal, whereas others displayed a considerable increase above normal. In these the PAI-1 staining was most intense immediately adjacent to the tumour margin. The granules of PAI-1 were more densely packed in the hepatocytes and present in a higher proportion of hepatocytes (fig 3) . In contrast, non-cirrhotic liver affected by primary hepatocellular carcinoma contained PAI-1 in similar quantities to those found in the normal liver sections. In one case the primary carcinoma was superimposed on cirrhosis and showed very little PAI-1 in the hepatocytes, which was consistent with the findings in cirrhosis alone (not shown).
Primary and secondary carcinoma cells infiltrating liver showed minimal PAI-1 staining. Fibrous tissue did contain some PAI-1, as in normal and cirrhotic liver sections.
The Lastly, the virtual absence of PAI-1 from tumour cells of primary hepatocellular carcinoma suggests that hepatoma cell lines may not be ideal for studying physiological regulation of PAI-1 in normal human liver.
